| 名稱(chēng) | BCR-ABL1 P223S/BaF3 |
| 型號(hào) | CBP73310 |
| 報(bào)價(jià) | ![]() |
| 特點(diǎn) | BCR-ABL1 [P223S]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- STING激動(dòng)劑和拮抗劑的篩選
- 【現(xiàn)貨上線(xiàn)】HRR-Related-28 Gene標(biāo)準(zhǔn)品
- 腫瘤免疫新型靶點(diǎn)——趨化因子受體
- BCR-ABL激酶抑制劑細(xì)胞篩選模型
- 選擇本公司的人結(jié)腸癌細(xì)胞株有3個(gè)理由
- CD74-ROS1的藥靶模型+DNARNA標(biāo)準(zhǔn)品+ddPCR試劑盒
- IL36靶點(diǎn)藥物細(xì)胞篩選模型藥
- 科學(xué)家如何深度破解癌癥基因組的奧秘?
- 【產(chǎn)品推介】腫瘤耐藥細(xì)胞株
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
聯(lián)系我們
電話(huà):4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73310BCR-ABL1 P223S/BaF3
- 詳細(xì)內(nèi)容
| CBP73310 | |
| I. Introduction | |
Cell Line Name: | BCR-ABL1 [P223S]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
| III. Representative Data | |
1.WB of BCR-ABL1 [P223S]/BaF3
| |
2.Sanger of BCR-ABL1 [P223S]/BaF3 Figure 2. BCR-ABL1 [P223S]/BaF3 P223S Figure 3. BCR-ABL1 [P223S]/BaF3 Fusion | |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 P223S Cells (C14). | |








會(huì)員_a.png)